How to leverage novel trial designs and real-world data to support a cancer drug submission with an evidence strategy that is both approvable and reimbursable.
Amy McKee, M.D., Chief Medical Officer and Global Head, Oncology Center of Excellence, Parexel
Advertisement
Articles by Amy McKee, M.D., Chief Medical Officer and Global Head, Oncology Center of Excellence, Parexel
Advertisement
Latest Updated Articles
Advertisement
Advertisement
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
